Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure

Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure

Introduction and objectives: Direct antiviral agents (DAAs) are very efficient in inhibiting hepatitis C virus and might be used to treat infections caused by other flaviviruses whose worldwide detection has recently increased. The aim of this study was to verify the efficacy of DAAs in inhibiting y...

Full description

Bibliographic Details
Main Authors: Érica Araújo Mendes, Denise Regina Bairros de Pilger, Ana Catharina de Seixas Santos Nastri, Fernanda de Mello Malta, Bruno dos Santos Pascoalino, Luiz Augusto Carneiro D’Albuquerque, Andrea Balan, Lucio Holanda Gondim de Freitas, Jr., Edison Luis Durigon, Flair José Carrilho, João Renato Rebello Pinho
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Annals of Hepatology
Subjects:
Acute hepatitis
Flavivirus
YFV
Treatment
Antiviral
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119322434

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119322434

Similar Items